Kenvue Inc. (KVUE) Earnings History

Kenvue Inc. - Q4 FY2025 EarningsBeat

Filed at: Feb 17, 2026, 4:46 PM EST|Read from source

EXECUTIVE SUMMARY

Kenvue ended 2025 with improved Q4 performance driven by disciplined execution and favorable year-ago comparisons. The company is focused on enhancing performance and progressing its value-creating combination with Kimberly-Clark, which is expected to close in the second half of 2026.

POSITIVE HIGHLIGHTS

  • •

    Q4 Net sales increased 3.2% year-over-year, with organic sales growing 1.2% and a foreign currency benefit of 2.1%.

    positive
  • •

    Q4 Operating income margin improved to 14.2% from 13.2% in the prior year period.

    positive
  • •

    Q4 Diluted EPS increased to $0.17 from $0.15 in the prior year period.

    positive
  • •

    Full year 2025 Net cash flows from operating activities increased to $2.2 billion from $1.8 billion in the prior year period, leading to a Free cash flow increase to $1.7 billion.

    positive

CONCERNS & RISKS

  • •

    Full year 2025 Net sales decreased 2.1% year-over-year, with organic sales declining 2.2% due to a 2.3% volume decrease.

    negative
  • •

    Q4 Organic sales declined 1.2%, driven by a 3.1% volume decrease, partially offset by favorable value realization.

    attention
  • •

    Full year 2025 Organic sales decline was driven by a 2.3% volume decrease, impacting the Self Care segment.

    negative
  • •

    Q4 Adjusted effective tax rate increased to 20.2% from 17.7% in the prior year period.

    attention
  • •

    Full year 2025 Adjusted gross profit margin declined 20 basis points to 60.2% from 60.4% in the prior year period.

    attention
  • •

    Full year 2025 Adjusted operating income margin decreased to 21.0% from 21.5% in the prior year period.

    attention

FINANCIAL METRICS

Revenue
Quarterly
$3.78B
+3.2%
Prior year: $3.66B
Annual (YTD)
$15.12B
N/A
Prior year: $15.46B
Net Income
Quarterly
$330.00M
+12.6%
Prior year: $293.00M
Annual (YTD)
$1.47B
N/A
Prior year: $1.03B
EPS (Diluted)
Quarterly
$0.17
+13.3%
Prior year: $0.15
Operating Income
Quarterly
$535.00M
N/A
EPS (Basic)
Quarterly
N/A
N/A

MARGIN ANALYSIS

Gross Margin
Current Quarter
56.5%
Prior Year
56.5%
YoY Change
0 bps
Operating Margin
Current Quarter
14.2%
Prior Year
13.2%
YoY Change
+100 bps
Net Margin
Current Quarter
8.7%
Prior Year
8.0%
YoY Change
+70 bps

Margin expansion indicates improving profitability and operational efficiency. Measured in basis points (bps): 100 bps = 1.0%.

REVENUE BY SEGMENT — Q4 FY2025 2025

VISUAL OVERVIEW

|
Self Care
0.0%
N/A
Skin Health and Beauty
0.0%
N/A
Essential Health
0.0%
N/A

DETAILED BREAKDOWN

|
SegmentCurrentPrior YrYoY% Total
Self Care
N/A———
Skin Health and Beauty
N/A———
Essential Health
N/A———
Total Revenue$0.00M——100.0%

Segment performance shows business unit health and growth drivers.

SPECIAL ITEMS & ADJUSTMENTS

Q4 2025
Impairment charges related to ORSL® trade name
Following regulatory changes in India.
+$23M
$0.01 per share
FY2025
Impairment charges related to ORSL® trade name
Following regulatory changes in India.
+$23M
$0.01 per share
FY2024
Impairment charges related to Dr.Ci:Labo® long-lived assets
+$488M
FY2024
Impairment charges on held for sale asset (Skillman, NJ)
+$68M
FY2024
Impairment charges on certain software development assets
+$22M
Q4 2025
Gain on sale of Skillman, New Jersey facility
+$17M
$0.01 per share
Total Impact
+$641M$0.01 per share

Special items are non-recurring events that may distort period-over-period comparisons. Analysts typically adjust for these when calculating normalized earnings.

MANAGEMENT COMMENTARY

Ended 2025 with stronger top- and bottom-line performance in the fourth quarter.

— Kenvue Inc., Q4 FY2025 2025 Earnings Call

Reflected both disciplined execution against strategic priorities and a more favorable year-ago comparison on sales.

— Kenvue Inc., Q4 FY2025 2025 Earnings Call

Focused on continuing to enhance performance while progressing toward completion of the value-creating combination with Kimberly-Clark.

— Kenvue Inc., Q4 FY2025 2025 Earnings Call

Commentary excerpts from earnings call transcripts provide management's perspective on performance, strategy, and outlook. Always review full transcripts for complete context.

OPERATIONAL METRICS

Research & Development
98.0M
-7.5% YoY
Prior year: 106.0M
dollars

Operational metrics provide insight into business drivers and customer engagement beyond traditional financial measures.

Related Research

Analysis

KVUE 10-K Analysis: Why Kenvue's Earnings Recovery Is 97% Non-Operational